(Q40748816)

English

Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes

scientific article published on May 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Todeschini G

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Veneri D

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Carlini S

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Pizzolo G

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ambrosetti A

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Bonesi R

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Cassibba V

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Vinante F

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Meneghini V

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Perona G

10

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 May 1991

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

137-146

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

21 January 2018

Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

21 January 2018

Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

21 January 2018

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

21 January 2018

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

21 January 2018

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

21 January 2018

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

[Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Proceedings: Causes of death in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved prognosis for granulocytopenic patients with gram-negative bacteremia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing incidence of Gram-positive sepsis in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Gram-negative septicemia in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Double beta-lactam therapy in the immunocompromised host.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090304

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.2900090304

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40748816&oldid=1906671515"